News | July 01, 2008

MMV forms Alliance with Accuray for CyberKnife Technology

July 2, 2008 - Montecito Medical Ventures (MMV) formed an alliance by purchasing two placement contracts from medical technology company Accuray, manufacturers of the CyberKnife radiosurgery system, creating a program that gives healthcare providers that are affiliated with Montecito Medical access to medical technologies through its financing program.

MMV will make a pool of investment capital for healthcare transactions available to providers interested in acquiring CyberKnife or other advanced medical technologies.

The CyberKnife Robotic Radiosurgery System is reportedly the world's only radiosurgery system that can treat tumors anywhere in the body with sub-millimeter accuracy. Using image guidance technology and computer controlled robotics, the CyberKnife System is designed to continuously track the tumor, detect its location and automatically make needed adjustments throughout the procedure. Because it is so precise, the CyberKnife system enables surgeons to be less invasive in their surgical procedures, and allows them to target tumors in any part of the body, including the head, neck, spine, lung, prostate, liver and pancreas. CyberKnife also provides an additional option for patients diagnosed with tumors believed to be inoperable, or for patients looking for an alternative to surgery.

MMV was launched in October 2007 to provide venture capital and partnership opportunities to physician groups in key markets across the country. A joint venture of the California-based Montecito Medical Investment Company, MMV targets resources where it has determined there is a need for expanded medical services, and where it has identified strong partners that have medical products or technologies that will benefit healthcare providers affiliated with MMIC. Capital investments will be targeted to real estate acquisition and development, and structured finance in medical technology.

For more information: www.accuray.com, www.montecitomedical.com

Related Content

First Hospitals Achieve Inter-System Connectivity Across Accuray Radiation Therapy Platforms
News | Radiation Therapy | January 19, 2018
Accuray Inc. announced recently that the Heidelberg University Hospital in Heidelberg, Germany, and Oscar Lambret...
RayStation Selected for New Carbon Ion Therapy Center in Japan
News | Treatment Planning | January 18, 2018
January 18, 2018 – RayStation has been chosen as the treatment planning system for a new carbon-ion therapy facility
Raysearch Receives First Order for the Raycare Oncology Information System
News | Oncology Information Management Systems (OIMS) | January 18, 2018
January 18, 2018 – Anderson Regional Cancer Center (ARCC) in Meridian, Mississippi, has placed the first order for...
Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
News | Radiation Therapy | January 03, 2018
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine
News | Radiation Therapy | January 02, 2018
IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian...
Study Finds Link Between Breast Cancer Treatments and Cellular Aging Markers
News | Women's Health | January 02, 2018
January 2, 2018 — A new study found women who had received chemotherapy and/or...
ACR Appropriateness Criteria Adds and Revises Topics for December 2017
News | Clinical Decision Support | December 29, 2017
December 29, 2017 — Radiologists can enhance the quality and effectiveness of care with the newest release of the ACR
Overlay Init